Trial intelligence / Profile preview

L-arginine plus N-acetylcysteine in coronary ischemic heart disease evaluated by exercise Tc-99m myocardial SPECT

2005-002072-15Phase 3Terminated

Sponsor
AOU Città della Salute e della Scienza di Torino
Start
Jul 2005
Modality
Small Molecules, Recombinant Proteins and Enzymes, Peptides
Countries
1
01

Overview

Phase 3 trial of arginine and acetylcysteine in coronary arteriosclerosis and type 2 diabetes mellitus (T2DM), sponsored by AOU Città della Salute e della Scienza di Torino. Started Jul 2005; status: terminated.

02

Drugs

arginineacetylcysteine
03

Conditions

coronary arteriosclerosistype 2 diabetes mellitus (T2DM)

Beyond the preview

Go deeper on 2005-002072-15.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2005-002072-15.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call